NDC 68180-211-01 - Losartan Potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68180-211
- Requested NDC
- 68180-211-01
- Package NDCs from labels
- 68180-211-06, 68180-211-09, 68180-211-03, 68180-211-01
- Manufacturer
- Lupin Pharmaceuticals, Inc. | LUPIN LIMITED
- Effective date
- 2026-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium - Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | Lupin Pharmaceuticals, Inc. | LUPIN LIMITED | 2026-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68180-211-01 | Losartan Potassium | 100 in 1 BOTTLE | TABLET | 100 | 25 | |
| 68180-211-03 | Losartan Potassium | 1000 in 1 BOTTLE | TABLET | 1000 | 25 | |
| 68180-211-06 | Losartan Potassium | 30 in 1 BOTTLE | TABLET | 30 | 25 | |
| 68180-211-09 | Losartan Potassium | 90 in 1 BOTTLE | TABLET | 90 | 25 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68180-211-03 | EA - Each | 68180-211 | 8ebb2128-5566-4e9f-8998-2e50e9b118da | 1 | 2012-07-24 |
| 68180-211-06 | EA - Each | 68180-211 | aecf4dc1-445c-48ab-9a0c-896255788080 | 1 | 2014-10-03 |
| 68180-211-09 | EA - Each | 68180-211 | a6e1d330-ee0d-4fd3-b902-7ea364037825 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.